Epinephrine Versus Norepinephrine for Cardiogenic Shock After Acute Myocardial Infarction.
Fiche publication
Date publication
juillet 2018
Journal
Journal of the American College of Cardiology
Auteurs
Membres identifiés du Cancéropôle Est :
Pr ROSSIGNOL Patrick
Tous les auteurs :
Levy B, Clere-Jehl R, Legras A, Morichau-Beauchant T, Leone M, Frederique G, Quenot JP, Kimmoun A, Cariou A, Lassus J, Harjola VP, Meziani F, Louis G, Rossignol P, Duarte K, Girerd N, Mebazaa A, Vignon P,
Lien Pubmed
Résumé
Vasopressor agents could have certain specific effects in patients with cardiogenic shock (CS) after myocardial infarction, which may influence outcome. Although norepinephrine and epinephrine are currently the most commonly used agents, no randomized trial has compared their effects, and intervention data are lacking.
Mots clés
acute myocardial infarction, cardiogenic shock, epinephrine, norepinephrine, vasopressor
Référence
J. Am. Coll. Cardiol.. 2018 Jul 10;72(2):173-182